Letter to the Editor: Stem Cell Politics
By Richard Hayes,
New York Times
| 05. 01. 2006
To the Editor:
Re "Democrats Hope to Divide G.O.P. Over Stem Cells" (news article, April 24):
I'm a lifelong Democrat, pro-choice on abortion and in favor of stem cell research. But over-the-top promotion of this research is a mistake that could come back to bite us, and its use as a wedge issue is ill advised.
Stem cells may still prove to be a therapeutic dry hole. If successfully developed, stem cell therapies are likely to be prohibitively expensive.
Stem cell research puts women who donate eggs at significant medical risk, and could foster trafficking in eggs from poor women in developing countries.
The same stem cell technologies that might have beneficial medical applications could be used by rogue scientists intent on creating human clones and genetically modified children.
Stem cell research should be allowed, but it should proceed cautiously, under tight federal oversight.
Richard Hayes
Executive Director
Center for Genetics and Society
Oakland, Calif., April 24, 2006
Related Articles
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Nahlah Ayed, CBC Listen | 10.22.2025
Egg freezing is one of today’s fastest-growing reproductive technologies. It's seen as a kind of 'fertility insurance' for the future, but that doesn’t address today’s deeper feelings of uncertainty around parenthood, heterosexual relationships, and the reproductive path forward. In this...
By [cites CGS' Katie Hasson], KCBS Radio | 11.19.2025
This is Ask An Expert, where every weekday at 9:20am, KCBS Radio is giving you direct access to top experts in various fields. Today: Gene-editing technology allows scientists to work with DNA in unprecedented ways, but there are larger scientific...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...